 |
|
The Implications of Choice
Prescribing Generic or Preferred Pharmaceuticals Improves Medication Adherence for Chronic Conditions
William H. Shrank, MD, MSHS;
Tuyen Hoang, PhD;
Susan L. Ettner, PhD;
Peter A. Glassman, MBBS, MSc;
Kavita Nair, PhD;
Dee DeLapp, RPh;
June Dirstine;
Jerry Avorn, MD;
Steven M. Asch, MD, MPH
Arch Intern Med. 2006;166:332-337.
Background A large proportion of Americans are enrolled in 3-tier pharmacy benefit plans. We studied whether patients enrolled in such plans who receive generic or preferred brand-name agents when initiating chronic therapy were more adherent to treatment than those who received nonpreferred brand-name medications.
Methods We analyzed pharmacy claims filled between October 1, 2001, and October 1, 2003, from a large health plan for 6 classes of chronic medications: 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors, calcium channel blockers, oral contraceptives, orally inhaled corticosteroids, angiotensin receptor blockers, and angiotensin-converting enzyme inhibitors. We measured adherence as the proportion of days covered (PDC) in each drug class during the first year of therapy. We evaluated how the formulary status of the initial prescription (generic, preferred, or nonpreferred) influenced PDC and adequate adherence, defined as PDC greater than 80%, over the subsequent year.
Results A total of 7532 new prescriptions were filled in 1 of the classes evaluated: 1747 (23.2%) for nonpreferred medications, 4376 (58.1%) for preferred drugs, and 1409 (18.7%) for generic drugs. After controlling for patient sociodemographic characteristics and drug class, PDC was 12.6% greater for patients initiated on generic medications vs nonpreferred medications (58.8% vs 52.2%; P<.001). The PDC was 8.8% greater for patients initiated on preferred vs nonpreferred medications (56.8% vs 52.2%; P<.001). Patients initiated on generic and preferred medications had 62% and 30% greater odds, respectively, of achieving adequate adherence compared with those who received nonpreferred medications.
Conclusion In 3-tier pharmacy benefit plans, prescribing generic or preferred medications within a therapeutic class is associated with improvements in adherence to therapy.
Author Affiliations: Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital and Harvard Medical School, Boston, Mass (Drs Shrank and Avorn); VA Greater Los Angeles Healthcare System, Los Angeles, Calif (Drs Hoang, Glassman, and Asch); Department of Medicine, The David Geffen School of Medicine at UCLA, Los Angeles (Drs Ettner, Glassman, and Asch); RAND Health, Santa Monica, Calif (Drs Glassman and Asch); Department of Pharmacy, University of Colorado Health Sciences Center, Denver (Dr Nair); Anthem Blue Cross and Blue Shield, Denver (Mss DeLapp and Dirstine); and Anthem Prescription Management, Denver (Mss DeLapp and Dirstine).
 CiteULike  Connotea  Delicious  Digg  Facebook  Reddit  Technorati  Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
Early Adopters of Electronic Prescribing Struggle to Make Meaningful Use of Formulary Checks and Medication History Documentation
Crosson et al.
J Am Board Fam Med 2012;25:24-32.
ABSTRACT
| FULL TEXT
The backlash against bioequivalence and the interchangeability of brand-name and generic drugs
Kesselheim
CMAJ 2011;183:1350-1351.
FULL TEXT
Addressing escalating health care costs in ageing populations by increasing generic medicine utilization
Simoens
Journal of Generic Medicines: The Business Journal for the Generic Medicines Sector 2011;8:150-156.
ABSTRACT
The Relative Cost-Effectiveness of Anticoagulants: Obvious, Except for the Cost and the Effectiveness
Avorn
Circulation 2011;123:2519-2521.
FULL TEXT
Promoting Persistence: Improving Adherence Through Choice of Drug Class
Choudhry
Circulation 2011;123:1584-1586.
FULL TEXT
Physician Perceptions About Generic Drugs
Shrank et al.
The Annals of Pharmacotherapy 2011;45:31-38.
ABSTRACT
| FULL TEXT
The Epidemiology of Prescriptions Abandoned at the Pharmacy
Shrank et al.
ANN INTERN MED 2010;153:633-640.
ABSTRACT
| FULL TEXT
Impact of generic substitution decision support on electronic prescribing behavior
Stenner et al.
J Am Med Inform Assoc 2010;17:681-688.
ABSTRACT
| FULL TEXT
State Generic Substitution Laws Can Lower Drug Outlays Under Medicaid
Shrank et al.
Health Aff (Millwood) 2010;29:1383-1390.
ABSTRACT
| FULL TEXT
Formulary Coverage for Lipid-Lowering Drugs Recommended for Children
Yoon et al.
CLIN PEDIATR 2009;48:609-613.
ABSTRACT
Equivalence of Generic and Brand-Name Drugs for Cardiovascular Disease--Reply
Kesselheim et al.
JAMA 2009;301:1655-1656.
FULL TEXT
Patients' Perceptions Of Generic Medications
Shrank et al.
Health Aff (Millwood) 2009;28:546-556.
ABSTRACT
| FULL TEXT
The Effect Of Medicare Part D Coverage On Drug Use And Cost Sharing Among Seniors Without Prior Drug Benefits
Schneeweiss et al.
Health Aff (Millwood) 2009;28:w305-w316.
ABSTRACT
| FULL TEXT
Effect of Electronic Prescribing With Formulary Decision Support on Medication Use and Cost
Fischer et al.
Arch Intern Med 2008;168:2433-2439.
ABSTRACT
| FULL TEXT
Clinical Equivalence of Generic and Brand-Name Drugs Used in Cardiovascular Disease: A Systematic Review and Meta-analysis
Kesselheim et al.
JAMA 2008;300:2514-2526.
ABSTRACT
| FULL TEXT
Evaluating Community Pharmacists' Perceptions and Practices on Generic Medicines: A Pilot Study from Peninsular Malaysia
Babar and Awaisu
Journal of Generic Medicines: The Business Journal for the Generic Medicines Sector 2008;5:315-330.
ABSTRACT
The International Pharmaceutical Market as a Source of Low-Cost Prescription Drugs for U.S. Patients
Kesselheim and Choudhry
ANN INTERN MED 2008;148:614-619.
ABSTRACT
| FULL TEXT
Medicaid's Prior Authorization Program And Access To Atypical Antipsychotic Medications
Polinski et al.
Health Aff (Millwood) 2007;26:750-760.
ABSTRACT
| FULL TEXT
Impact Of Medicaid Prior Authorization On Angiotensin-Receptor Blockers: Can Policy Promote Rational Prescribing?
Fischer et al.
Health Aff (Millwood) 2007;26:800-807.
ABSTRACT
| FULL TEXT
Effect of Content and Format of Prescription Drug Labels on Readability, Understanding, and Medication Use: A Systematic Review
Shrank et al.
The Annals of Pharmacotherapy 2007;41:783-801.
ABSTRACT
| FULL TEXT
Extensions Of Intellectual Property Rights And Delayed Adoption Of Generic Drugs: Effects On Medicaid Spending
Kesselheim et al.
Health Aff (Millwood) 2006;25:1637-1647.
ABSTRACT
| FULL TEXT
Physicians' Perceived Knowledge of and Responsibility for Managing Patients' Out-of-Pocket Costs for Prescription Drugs
Shrank et al.
The Annals of Pharmacotherapy 2006;40:1534-1540.
ABSTRACT
| FULL TEXT
|
